Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases
International Journal of Molecular Sciences · 26.06.2023 · 24 (13) · 10670
DOI: 10.3390/ijms241310670 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.06.2023. Verfasst von Maddalen Zufiaurre-Seijo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Cone-Rod Dystrophies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Mutations in the photoreceptor-specific C2orf71 gene (also known as photoreceptor cilium actin regulator protein PCARE) cause autosomal recessive retinitis pigmentosa type 54 and cone-rod dystrophy. No treatments are available for patients with C2orf71 retinal ciliopathies exhibiting a severe clinical phenotype. Our understanding of the disease process and the role of PCARE in the healthy retina significantly limits our capacity to transfer recent technical developments into viable therapy choices. This study summarizes the current understanding of C2orf71-related retinal diseases, including their clinical manifestations and an unclear genotype-phenotype correlation. It discusses molecular and functional studies on the photoreceptor-specific ciliary PCARE, focusing on the photoreceptor cell and its ciliary axoneme. It is proposed that PCARE is an actin-associated protein that interacts with WASF3 to regulate the actin-driven expansion of the ciliary membrane during the development of a new outer segment disk in photoreceptor cells. This review also introduces various cellular and animal models used to model these diseases and provides an overview of potential treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Zufiaurre-Seijo, M., García-Arumí, J., & Duarri, A. (2023). Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases. International Journal of Molecular Sciences, 24(13), 10670. https://doi.org/10.3390/ijms241310670
Vancouver
Zufiaurre-Seijo M, García-Arumí J, Duarri A. Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases. International Journal of Molecular Sciences. 2023;24(13):10670. doi:10.3390/ijms241310670
BibTeX
@article{ZufiaurreSeijo2023,
author = {Zufiaurre-Seijo, Maddalen and García-Arumí, José and Duarri, Anna},
title = {Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {13},
pages = {10670},
doi = {10.3390/ijms241310670}
}
EUVIMED